I am a general and geriatric psychiatrist in Wilmington, Delaware. I completed psychiatric training at The Johns Hopkins University, as well as a neuropsychiatry research fellowship at
Hopkins in 1990. Since then, I have been engaged in the private practice of psychiatry, in both inpatient and outpatient settings, in Wilmington. In addition, I have been Principal
Investigator in numerous clinical research studies, Medical Director of Electroconvulsive (ECT) Services at Christiana Care Health System, and have co-authored several peer-reviewed journal articles
and book chapters on depression following stroke. I have lectured extensively in the community on behalf of various support groups, pharmaceutical companies, and church-sponsored mental health
seminars. I am Board Certified in Psychiatry, with Added Qualifications in Geriatric Psychiatry. I live in Chester County, Pennsylvania, with my wife and three children.
Joseph Baugher Bryer, M.D.
Office Address: 2300 Pennsylvania Avenue, Suite 3B Wilmington, Delaware 19806
Communication: Telephone: (302) 426-9440 Fax: (302) 426-0329
1977-1981 Bucknell University, B.S. in Animal Behavior
1981-1985 Medical College of Pennsylvania, M.D. degree
Postgraduate Training: 1985-1986 Combined internship in Psychiatry and Medicine, Francis Scott Key Medical Center, Baltimore, MD
1986-1988 Residency in Psychiatry, The Johns Hopkins Hospital, Baltimore MD
1988-1989 Chief Resident in Psychiatry, The Johns Hopkins Hospital, Baltimore, MD
1989-1990 Research Fellow in Neuropsychiatry, The Johns Hopkins University, Baltimore MD
1999-present Medical Director of Electroconvulsive Therapy, Christiana Care Health System, Wilmington, DE
1990-present Private practice of Psychiatry (full-time since June 1999) Wilmington, DE
Hospital Administrative Appointments:
1/99-6/99 Medical Director, MeadowWood Behavioral Health System, New Castle, DE
1993-1998 Medical Director of Adult Services, MeadowWood Behavioral Health System, New Castle, DE
1993-1999 Chairman, Pharmacy & Therapeutics Committee, MeadowWood Behavioral Health System, New Castle, DE
1992-1993 Chairman, Quality Improvement Committee, Department of Psychiatry, The Medical Center of Delaware, Wilmington, DE
1990-1993 Director of Psychiatric Rehabilitation Consultation, The Medical Center of Delaware, Wilmington, DE
Specialty Certification: 1990 American Board of Psychiatry and Neurology, with added Qualifications in Geriatric
1990 Delaware (Active)
1985 Maryland (Inactive)
1985 Alpha Omega Alpha Medical Honor Society
1990-present American Psychiatric Association
1990-present Delaware Psychiatric Society
1991-1992 Golden Apple Award, for Excellence in Teaching, Delaware State Hospital Psychiatry Residency Program
1994-present Association for Convulsive Therapy
1996-2000 Principal Investigator, HealthCore, Newark, DE
1995-1996 Sub-Investigator, Clary Research Associates
1989-1990 Research Fellow in Neuropsychiatry, The Johns Hopkins University—human, primate and rodent studies of mechanisms of depression following stroke
1982 Fellowship, The Medical College of Pennsylvania, Department of Pharmacology—investigating the effects of environmental stress on beta-adrenergic receptor systems in rat brain
Participant in the Following Clinical Trials:
Phase III Trials:
· Paroxetine vs. Imipramine vs. Placebo in Bipolar Depression, SmithKline Beecham, 1995
· Paroxetine vs. Placebo in Generalized Social Phobia, SmithKline Beecham, 1995-1996
· Paroxetine vs. Placebo in Long Term Treatment of Social Phobia, SmithKline Beecham, 1995-1996
· IR Paroxetine vs. Modified Release Paroxetine in Major Depression in the Elderly, SmithKline Beecham, 1996-1997
· Modified Release Paroxetine vs. Placebo in Panic Disorder, SmithKline Beecham, 1996-1997
· Fixed-dose Paroxetine vs. Placebo in Generalized Social Phobia, SmithKline Beecham, 1997
· Open Label M10907 in Schizophrenia of Other Psychotic Disorders, Hoechst Marion Roussel, 1998-1999
Phase IV Trials
· Sertraline vs. Placebo in Elderly Outpatients with Depression, Pfizer, 1997-1998
· Buspirone vs. Placebo in Children and Adolescents with Generalized Anxiety Disorder, Bristol-Myers Squibb, 1999
Presentations at Meetings:
Bryer, J.B., Starkstein, S.E., Parikh, R., and Robinson, R.G.: Reduction of CSF monoamine in post-stroke depression. Paper presented at the American Psychiatric Association Convention, New York, NY, May 16, 1990
Yang, N.C., Leichner, P., Pearlson, G.D., Mendizabal, J., Bryer, J.B., Dhingra, U., Tien, A., and Hawkins, W: CT brain volumetrics for Alzheimer’s Disease. Paper presented by Dr. Yang at the 1998 World Congress on Medical Physics and Biomedical Engineering
Caudarella, M, and Bryer, J.B.: Effect of kindling and post-trial electrical stimulation on discrimination learning. Abstract presented by Dr. Caudarella at the Society for Neuroscience Convention, 1981
Lectures By Invitation (Selected):
· Effects of Alzheimer’s Disease on the Family. Presented at the Alzheimer’s Association annual conference, Wilmington DE, November 8, 1990.
· Cognitive complications of alcohol abuse. Presented at the Department of Psychiatry Grand Rounds, The Medical Center of Delaware, November 1990.
· False memory syndrome. Presented at Grand Rounds, MeadowWood Hospital, New Castle DE, January 1995.
· Electroconvulsive therapy. Presented at Grand Rounds, MeadowWood Hospital, New Castle DE, March 1996.
· Understanding bipolar disorder. MeadowWood Hospital Continuing Education Lecture Series, New Castle DE, 1993.
· Seasonal affective disorder. . MeadowWood Hospital Continuing Education Lecture Series, New Castle DE, 1993.
· Psychiatric complications of Alzheimer’s Disease. Presented at Leader Nursing Home, Wilmington DE, October 21, 1991
· Bipolar Disorder. New Directions support group, Wilmington DE, 1994
· Post-stroke depression. Stroke Club support group, Jewish Community Center, Wilmington DE, June 1996
· Families and professionals: A partnership to recovery. Alliance for the Mentally Ill in Delaware Annual Conference, Wilmington DE, October 8, 1998
· Non-pharmacologic treatments of depression: ECT, phototherapy, and sleep deprivation. New Directions support group, Wilmington DE, 1999.
· Ask the doctor. Alliance for the Mentally Ill in Delaware Annual Conference, Wilmington DE, October 7, 1999
Numerous additional presentations at churches, hospitals, retirement communities, and to physicians
Bryer, J.B., Starkstein, S.E., Votypka, V., Parikh, R.M., Price, T.R., and Robinson, R.G. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report. The Journal of Neuropsychiatry, Vol 4(4), 1992, pp. 440-442.
Bryer, J.B., Starkstein, S.E., Mayberg, H.S., and Robinson, R.G. Neuro-imaging in Secondary Affective Disorders, in P. Hauser (ed.) Brain Imaging in Affective Disorders, American Psychiatric Press, pp. 113-135.
Belcheva, I., Starkstein, S.E., Honig, M., Bryer, J.B., Moran, T.H., and Robinson, R.G. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens. Brain Research, Vol 533, 1991 pp. 286-291.
Starkstein, S.E., Bryer, J.B., Berthier, M.L., Cohen, B., Price, T.R., and Robinson, R.G. Depression after stroke: the importance of cerebral hemisphere asymmetries. The Journal of Neuropsychiatry, Vol3(3), 1991, pp. 276-285.